311 related articles for article (PubMed ID: 30511425)
1. An autopsy case of progressive multifocal leukoencephalopathy after rituximab therapy for malignant lymphoma.
Muto R; Sugita Y; Momosaki S; Ito Y; Wakugawa Y; Ohshima K
Neuropathology; 2019 Feb; 39(1):58-63. PubMed ID: 30511425
[TBL] [Abstract][Full Text] [Related]
2. Progressive Multifocal Leukoencephalopathy Following Treatment with Rituximab in an HIV-Negative Patient with Non-Hodgkin Lymphoma. A Case Report and Literature Review.
Felli V; Di Sibio A; Anselmi M; Gennarelli A; Sucapane P; Splendiani A; Catalucci A; Marini C; Gallucci M
Neuroradiol J; 2014 Dec; 27(6):657-64. PubMed ID: 25489887
[TBL] [Abstract][Full Text] [Related]
3. Progressive multifocal leukoencephalopathy (PML) in a patient with lymphoma treated with rituximab: A case report and literature review.
Al-Tawfiq JA; Banda RW; Daabil RA; Dawamneh MF
J Infect Public Health; 2015; 8(5):493-7. PubMed ID: 25666327
[TBL] [Abstract][Full Text] [Related]
4. Infratentorial onset of progressive multifocal leukoencephalopathy in a patient with systematic lupus erythematosus complicated with lymphoma: a case report.
Sakuraba M; Watanabe S; Nishiyama Y; Takahashi K; Nakamichi K; Suzuki M; Nawata T; Komai K; Gono T; Takeno M; Suzuki T; Kimura K; Kuwana M
Mod Rheumatol Case Rep; 2021 Jul; 5(2):272-277. PubMed ID: 33719867
[TBL] [Abstract][Full Text] [Related]
5. A role for susceptibility weighted imaging in progressive multifocal leukoencephalopathy.
Yap SM; Murray B; Lynch T; Kavanagh E; MacMahon P
Ir Med J; 2017 Apr; 110(4):549. PubMed ID: 28665088
[TBL] [Abstract][Full Text] [Related]
6. Rituximab-associated progressive multifocal leukoencephalopathy derived from non-Hodgkin lymphoma: neuropathological findings and results of mefloquine treatment.
Sano Y; Nakano Y; Omoto M; Takao M; Ikeda E; Oga A; Nakamichi K; Saijo M; Maoka T; Sano H; Kawai M; Kanda T
Intern Med; 2015; 54(8):965-70. PubMed ID: 25876582
[TBL] [Abstract][Full Text] [Related]
7. Development of demyelinating lesions in progressive multifocal leukoencephalopathy (PML): Comparison of magnetic resonance images and neuropathology of post-mortem brain.
Ono D; Shishido-Hara Y; Mizutani S; Mori Y; Ichinose K; Watanabe M; Tanizawa T; Yokota T; Uchihara T; Fujigasaki H
Neuropathology; 2019 Aug; 39(4):294-306. PubMed ID: 31155757
[TBL] [Abstract][Full Text] [Related]
8. Cerebellar form of progressive multifocal leukoencephalopathy in a patient with chronic renal failure.
Irie T; Kasai M; Abe N; Seto K; Naohara T; Kawamura K; Higa T; Sano K; Takahashi H; Nagashima K
Intern Med; 1992 Feb; 31(2):218-23. PubMed ID: 1318117
[TBL] [Abstract][Full Text] [Related]
9. [A case of progressive multifocal leukoencephalopathy presenting white matter MRI lesions extending over the cerebral cortex and a marked decrease in cerebral blood flow on SPECT, and associated with HTLV-I infection].
Takase K; Ohyagi Y; Furuya H; Nagashima K; Taniwaki T; Kira J
Rinsho Shinkeigaku; 2005 Jun; 45(6):426-30. PubMed ID: 16022467
[TBL] [Abstract][Full Text] [Related]
10. Contrast-enhancing progressive multifocal leukoencephalopathy: radiological and pathological correlations: case report.
Woo HH; Rezai AR; Knopp EA; Weiner HL; Miller DC; Kelly PJ
Neurosurgery; 1996 Nov; 39(5):1031-4; discussion 1034-5. PubMed ID: 8905761
[TBL] [Abstract][Full Text] [Related]
11. Progressive multifocal leukoencephalopathy in myelodysplastic syndrome involving pure red cell aplasia.
Chihara D; Takeoka T; Shirase T; Kishimoto W; Arimoto-Miyamoto K; Tsuji M; Ohno T
Intern Med; 2010; 49(21):2347-52. PubMed ID: 21048373
[TBL] [Abstract][Full Text] [Related]
12. An autopsy case of progressive multifocal leukoencephalopathy with massive iron deposition in juxtacortical lesions.
Okamoto K; Takeda A; Hatsuta H; Sano T; Takao M; Ohsawa M; Miki Y; Nakamichi K; Itoh Y
Neuropathology; 2023 Oct; 43(5):396-402. PubMed ID: 36847459
[TBL] [Abstract][Full Text] [Related]
13. Progressive multifocal leukoencephalopathy in a lymphoma patient with complete remission after treatment with cytostatics and rituximab: case report and review of the literature.
Freim Wahl SG; Folvik MR; Torp SH
Clin Neuropathol; 2007; 26(2):68-73. PubMed ID: 17416105
[TBL] [Abstract][Full Text] [Related]
14. [Fatal neurological side effect of anti-CD20 antibody treatment].
Schmidt K; Skusa R; Großmann A
Inn Med (Heidelb); 2023 Feb; 64(2):193-196. PubMed ID: 36422661
[TBL] [Abstract][Full Text] [Related]
15. Progressive multifocal leukoencephalopathy in AIDS: a clinicopathologic study and review of the literature.
von Einsiedel RW; Fife TD; Aksamit AJ; Cornford ME; Secor DL; Tomiyasu U; Itabashi HH; Vinters HV
J Neurol; 1993 Jul; 240(7):391-406. PubMed ID: 8410079
[TBL] [Abstract][Full Text] [Related]
16. Fatal progressive multifocal leukoencephalopathy in a patient with non-Hodgkin lymphoma treated with rituximab.
Paues J; Vrethem M
J Clin Virol; 2010 Aug; 48(4):291-3. PubMed ID: 20558102
[TBL] [Abstract][Full Text] [Related]
17. Progressive multifocal leukoencephalopathy in idiopathic CD4
Aggarwal D; Tom JP; Chatterjee D; Goyal M
Neuropathology; 2019 Dec; 39(6):467-473. PubMed ID: 31584217
[TBL] [Abstract][Full Text] [Related]
18. Pathology for severe inflammatory PML with PD1/PD-L1 expression of favorable prognosis: What's a prognostic factor for PML-IRIS?
Shishido-Hara Y; Akimoto J; Fukami S; Kohno M; Matsubayashi J; Nagao T
Neuropathology; 2024 Feb; 44(1):47-58. PubMed ID: 37424276
[TBL] [Abstract][Full Text] [Related]
19. Posterior Fossa Progressive Multifocal Leukoencephalopathy Secondary to Rituximab.
Guduru M; Bendi VS; Bebawy MS; Bande D; Matta A
Cureus; 2020 Oct; 12(10):e10888. PubMed ID: 33178540
[TBL] [Abstract][Full Text] [Related]
20. Progressive multifocal leukoencephalopathy associated with a lymphoproliferative disorder treated with pembrolizumab.
Holmes A; Wellings T; Walsh O; Rowlings P
J Neurovirol; 2020 Dec; 26(6):961-963. PubMed ID: 32910430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
